Health Canada Approves Paladin Labs Inc. (CC:PLB) Silenor New Drug Submission
12/18/2012 7:30:09 AM
More...
|
Somaxon Pharmaceuticals, Inc. (SOMX) Acquired by Pernix Therapeutics, Inc. (PTX) for $25 Million
12/11/2012 7:33:39 AM
More...
|
Somaxon Pharmaceuticals, Inc. (SOMX) Reports Third Quarter 2012 Financial Results
11/1/2012 7:28:50 AM
More...
|
Somaxon Pharmaceuticals, Inc. (SOMX) to Report Third Quarter 2012 Results and Conduct Conference Call on Wednesday, October 31
10/23/2012 9:03:43 AM
More...
|
Somaxon Pharmaceuticals, Inc. (SOMX) Approves 1-for-8 Reverse Stock Split and Decrease in the Number of Authorized Shares of Its Common Stock to 25,000,000 Shares
10/11/2012 9:21:01 AM
More...
|
Somaxon Pharmaceuticals, Inc. (SOMX) to Present at the Stifel Nicolaus 2012 Healthcare Conference
8/28/2012 9:24:10 AM
More...
|
Somaxon Pharmaceuticals, Inc. (SOMX) Reports Second Quarter 2012 Financial Results
8/8/2012 9:56:13 AM
More...
|
Somaxon Pharmaceuticals, Inc. (SOMX) to Report Second Quarter 2012 Results and Conduct Conference Call on Tuesday, August 7
7/30/2012 9:44:39 AM
More...
|
Somaxon Pharmaceuticals, Inc. (SOMX) Completes $3.0 Million Registered Direct Offering
7/25/2012 9:19:55 AM
More...
|
Somaxon Pharmaceuticals, Inc. (SOMX) to Raise $3.0 Million in Registered Direct Offering
7/20/2012 9:41:07 AM
More...
|
|